- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02571647
Evaluation of Screening for Visual Disorders of the Old Subject in Consultation Memory (EVAM)
May 9, 2019 updated by: Nantes University Hospital
Visual disorders are often overlooked in the treatment of cognitive disorders of the elderly.
Yet the visual deficit impacts the quality of life, the evolution of the autonomy and psycho-behavioral disorders in cognitive diseases.
The main objective of the study is to evaluate the prevalence of visual disorders among elderly patients at consultant outpatient center of Nantes clinical gerontology as part of the consultation geriatric memory.
Secondary objectives are to describe ophthalmological diseases detected and taken into the proposed ophthalmic load, to determine if there are associations between eye diseases and cognitive disorders, to estimate the proportion of patients who may have an ophthalmologic evaluation to determine the cognitive profiles and geriatric evaluation and ocular pathological, depending on the assessment of arterial stiffness.
The results of this study will build a testing strategy to promote access of older patients with cognitive impairment to vision care.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nantes, France, 44093
- Nantes University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients eligible for the study will be all patients 65 and older, in consultation from memory or day hospital Clinical Gerontology ambulatory center at Nantes University Hospital.
Geriatrician who will see the patient Clinical Gerontology ambulatory center be informed of the study and gather written consent and that of his legal representative, if applicable.
Description
Inclusion Criteria:
- Elderly over 65 years,
- Subject to consultation from memory Clinical Gerontology ambulatory center Nantes University Hospital
- Current use of spoken French
- Patient (or legal guardian, if applicable) has given its written consent
- Patient affiliated to a social security scheme
Exclusion Criteria:
- Life expectancy lower 1 year
- Mobility limitation preventing the installation retinal
- Major disorders and productive behavior does not allow participation in diagnostic procedures.
- Inability to respond to instructions when performing ophthalmological examinations.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of participants with presence of an ophthalmological disease (symptomatic or not) after clinical evaluation.
Time Frame: 6 month
|
6 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gilles BERRUT, Pr, Nantes University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 11, 2016
Primary Completion (Actual)
April 24, 2017
Study Completion (Actual)
April 24, 2017
Study Registration Dates
First Submitted
October 5, 2015
First Submitted That Met QC Criteria
October 6, 2015
First Posted (Estimate)
October 8, 2015
Study Record Updates
Last Update Posted (Actual)
May 10, 2019
Last Update Submitted That Met QC Criteria
May 9, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC15_0219
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Visual Disorders
-
Stanford UniversityEnrolling by invitationGlaucoma | Visual Fields | Eye Disorders | Visual Field TestsUnited States
-
National Taiwan University HospitalRecruitingCerebral Visual Impairment | Visual Rehabilitation | Oddball Design | Passive Visual Stimulation | Perceptual LearningTaiwan
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven; University Ghent; Research Foundation Flanders; Free University of Brussels and other collaboratorsUnknowniVision - Development of a Game-based Therapy for Children With Cerebral Visual Impairment (iVision)Visual Perceptual Weakness (Disorder) | Cerebral Visual ImpairmentBelgium
-
Medipol UniversityNot yet recruitingEFFECTS OF A VISION-FOCUSED OCCUPATIONAL THERAPY PROGRAM ON VISUAL SKILLS IN PRIMARY SCHOOL CHILDRENVisual Attention | Visual Deficiencies
-
Johnson & Johnson Vision Care, Inc.CompletedVisual DisordersUnited States
-
University of ZurichBalgrist University HospitalRecruitingEpilepsy | Migraine | Visual Snow SyndromeSwitzerland
-
Xuanwu Hospital, BeijingNot yet recruitingVisual Field Loss | Visual Field Defects
-
University Health Network, TorontoNot yet recruitingStroke | Cognitive Impairment | Virtual Reality | Visual Impairment | Low Vision | Driving Impaired | Visual Spatial Processing | Visual Processing Speed | Visual Field DefectCanada
-
University of California, San FranciscoNational Eye Institute (NEI)CompletedRepetitive Transcranial Magnetic Stimulation | Visual Attention | Visual Cortical PlasticityUnited States
-
Universitaire Ziekenhuizen KU LeuvenVrije Universiteit Brussel; Fund for Scientific Research, Flanders, BelgiumCompletedCerebral Visual ImpairmentBelgium
Clinical Trials on Non interventional study
-
Ohio State University Comprehensive Cancer CenterCompletedHeavy Metal Exposure From VapingUnited States
-
Portsmouth Hospitals NHS TrustArdia Digital Health LtdNot yet recruitingChronic Kidney Disease
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI)RecruitingProstate CarcinomaUnited States
-
Mayo ClinicRecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterLilly FoundationRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Advanced Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Enrolling by invitationBarrett Esophagus | Esophageal AdenocarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States
-
Roswell Park Cancer InstituteRecruitingCigarette Smoking-Related CarcinomaUnited States
-
Children's Oncology GroupNot yet recruitingChildhood Hematopoietic and Lymphatic System Neoplasm | Childhood Malignant Solid Neoplasm
-
Ohio State University Comprehensive Cancer CenterAmerican Association for Cancer ResearchRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Breast Carcinoma | Hormone Receptor-Positive Breast CarcinomaUnited States